RxDoctor Payments Data

Mark Tenny, DPM

Foot & Ankle Surgery · Albuquerque, NMNPI 1982010500

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Paragon 28, Inc. at 29.7% of the total. Reporting peaked in 2022 at $2,665 and has fallen 65.2% since, to $927 in 2025.

$8,377in general payments, 2019–2025

Across 182 payments — averaging $46.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$2K
  • Stryker$2K
  • Treace Medical Concepts, Inc.$2K
  • Smith+Nephew$846
  • Kerecis Limited$393
  • Organogenesis Inc.$179
  • plus $837 from 18 others

What the payments were for

  • Travel & lodging$3,44341%
  • Food & beverage$4,93359%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,377 in reported general payments places this provider in the 80th percentile of 69 foot & ankle surgery providers in New Mexico.

See all foot & ankle surgery providers in New Mexico

Medicare billing

Part B allowed, 2024
$235,765
Medicare patients
251
Services billed
1,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl35$803
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen16$190
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$129
Meloxicam14$66
Tramadol Hcl42$57
Amitriptyline Hcl12$32

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →